🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06327906
Recruiting Observational

A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China

NCT06327906 · tracked via the Priya Life Science China tracker
Sponsor
Qilu Hospital of Shandong University
Phase
Observational
Started
2023-11-15
Last updated
2024-03-25

Condition(s) studied

Child AllergyNeurodevelopmental Disorders

Study summary

In this study, a birth cohort was established to demonstrate the causal relationship between allergies and neurodevelopment disorders in infants and young children, and to find out the influencing factors of neurodevelopment disorders in early life.

Eligibility

Sex
ALL
Min age
1 Minute
Max age
42 Days
Healthy volunteers
No
Inclusion Criteria: * ①Allergic questionnaire results were positive. * The living area is Jinan City and its surrounding areas in Shandong Province, which is convenient for follow-up. Exclusion Criteria: * There is a clear diagnosis of brain developmental disorders * Psychological diseases * History of craniocerebral trauma or brain organic disease ④Major physical diseases ⑤Visual and auditory disorders ⑥ Epilepsy ⑦Intellectual disabilities

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Qilu Hospital of Shandong University Jinan Shandong Recruiting

More Qilu Hospital of Shandong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06327906 on ClinicalTrials.gov ↗ ← All trials in China